Integrated Drug Discovery

Axcelead Booster

Accelerating Drug Candidate Generation

With Our Pharma-originated Discovery Platform

What is Axcelead Booster (A-Booster)?
— The Future of Data-Driven Drug Candidate Generation

A-Booster is a data-driven drug discovery solution designed to shorten the time to candidate generation.

Clients can jump-start from existing hits or leads of our 1,000 pharma-originated legacy projects. By working in close partnership with clients, we accelerate the path by leveraging our robust database, AI trained on this wealth of knowledge, expert drug discovery scientists, and comprehensive drug discovery platforms — delivering qualified candidates in record time.

Your strategic advantages
  • Save time and resources with pre-qualified hit/lead compounds, proprietary data, and robust assay systems
  • Expand your pipeline by unlocking new opportunities from 1000 legacy projects
  • Leverage pharma-grade lab-in-the-loop expertise with proprietary AI tools
  • Gain full ownership of co-created IP

Drug Target

The 1,000 projects cover diverse therapeutic areas and target classes, including GPCRs, kinases, ion channels, enzymes, nuclear receptors, and PPIs — ready to support your next-generation programs.

Proven Track Record

Real-world examples show how quickly our clients achieved their drug discovery projects goals with us, transforming discovery efficiency through our AI-powered DMTA cycles and data-driven optimization.

6 Months
to identify
promising leads
1 Year
to nominate
drug candidates

Ready to Accelerate Your Drug Candidate Generation?

If you have any diseases of interest, target classes, or specific targets in mind, please feel free to contact us. Our team will investigate the legacy projects and respond within 2–3 business days. We will tailor a drug candidate generation strategy for you.

We are ready to partner with you.